Latest Pneumococcal conjugate vaccine Stories
Prevention and treatment of pneumonia are critical to reducing child mortality, reaching Millennium Development Goal 4.
According to a new report, fewer US patients are receiving inappropriate antibiotics for coughs, colds, and ear infections.
COLLEGEVILLE, Pa., Aug. 11 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced it received notice that the action date for the U.S.
MADISON, N.J., July 23 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) today reported results for the 2009 second quarter and first half ended June 30, 2009. Worldwide net revenue decreased 4% to $5.7 billion for the 2009 second quarter and decreased 5% to $11.1 billion for the 2009 first half.
MADISON, N.J., July 20 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) today announced that its stockholders overwhelmingly approved the adoption of its merger agreement with Pfizer (NYSE: PFE) at Wyeth's Annual Meeting of Stockholders.
COLLEGEVILLE, Pa., July 14 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the Chilean Ministry of Health, MINSAL (Ministerio de Salud), has become the first government agency to approve Prevenar 13* Valent, (Pneumococcal Conjugate Vaccine 13 Valent (Diphtheria CRM(197) Protein)) for infants and young children.
The World Health Organization (WHO) has now approved a new cervical cancer vaccine from pharmaceutical company GlaxoSmithKline.
Infants who received two or three primary doses of the 7-valent pneumococcal conjugate vaccine (PCV-7) both had a decreased rate of carrying pneumococcal microorganisms that can cause pneumonia and other infections, compared to infants who were not vaccinated, according to a study in the July 8 issue of JAMA.
The Bill & Melinda Gates Foundation and the governments of Britain, Italy, Canada, Russia and Norway announced a $1.5 billion initiative on Friday to provide poor nations better access to vaccines against pneumococcal disease such as meningitis and pneumonia.
A $1.5 billion plan to save the world's poorest children from pneumococcal diseases was activated Friday in Lecce, Italy, international aid groups said. Representatives of five countries and four international aid groups officially made good on commitments promised in 2007 to speed delivery of pneumococcal vaccines that kill 1.6 million people year, including an estimated 1 million children under age 5. Italy donated $635 million, Britain $485 million, Canada $200 million, Russia $80 million,...